Pertussis Vaccination for Health Care Workers

Author:

Sandora Thomas J.1234,Gidengil Courtney A.1234,Lee Grace M.1234

Affiliation:

1. Division of Infectious Diseases, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts

2. Department of Laboratory Medicine, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts

3. Harvard Pediatric Health Services Research Fellowship Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts

4. Department of Ambulatory Care and Prevention, Harvard Medical School & Harvard Pilgrim Health Care, Boston, Massachusetts

Abstract

SUMMARY Pertussis, an acute respiratory infection caused by Bordetella pertussis, classically manifests as a protracted cough illness. The incidence of pertussis in the United States has been increasing in recent years. Immunity wanes after childhood vaccination, leaving adolescents and adults susceptible to infection. The transmission of pertussis in health care settings has important medical and economic consequences. Acellular pertussis booster vaccines are now available for use and have been recommended for all adolescents and adults. These vaccines are safe, immunogenic, and effective. Health care workers are a priority group for vaccination because of their increased risk of acquiring infection and the potential to transmit pertussis to high-risk patients. Health care worker vaccination programs are likely to be cost-effective, but further research is needed to determine the acceptability of pertussis vaccines among health care workers, the duration of immunity after booster doses, and the impact of vaccination on the management of pertussis exposures in health care settings.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Reference104 articles.

1. American Academy of Pediatrics. 2007. Pertussis (whooping cough), p. 498-520. In L. K. Pickering (ed.), Red Book: 2006 report of the Committee on Infectious Diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, IL. http://aapredbook.aappublications.org/cgi/content/full/2006/1/3.96 .

2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine. 2008

3. Aoyama, T., K. Sunakawa, S. Iwata, Y. Takeuchi, and R. Fujii. 1996. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J. Pediatr.129:761-764.

4. Bace, A., T. Zrnic, J. Begovac, N. Kuzmanovic, and J. Culig. 1999. Short-term treatment of pertussis with azithromycin in infants and young children. Eur. J. Clin. Microbiol. Infect. Dis.18:296-298.

5. Baggett, H. C., J. S. Duchin, W. Shelton, D. M. Zerr, J. Heath, I. R. Ortega-Sanchez, and T. Tiwari. 2007. Two nosocomial pertussis outbreaks and their associated costs—King County, Washington, 2004. Infect. Control Hosp. Epidemiol.28:537-543.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3